Healthy Volunteers Clinical Trial
Official title:
Effect of Choice on Food Pleasure Using fMRI
Previous studies have suggested that consumers who can choose what to eat could find food more pleasant, and consume more of that food, than when in absence of choice. However cognitive mechanisms that could explain the effect of choice have not been investigated. The study consists in a fMRI experiment intended to observe the effect of the presence of choice on brain activity following consumption of a fruit-flavored drink, compared to the brain activity when the same drink is consumed without choice. It is suggested that consumers will appreciate drinks they chose better, and that the activity in gustatory and reward regions will change accordingly to changes in declared food pleasure.
The study will include one inclusion session (S1), one out-of-the-magnet tasting session
(S2), and one fMRI session (S3). For all sessions, study drinks used are fruit-flavored
drinks and fruit juices available on the French market. All subjects will undergo the same
protocol, except for the choice of the three study drinks that will be done individually.
S1. After the inclusion/exclusion criteria have been verified, the subjects will perform
tests to verify their gustatory/olfactory functions (four basic tastes testing and ETOC
test). They will then taste study drinks, blindly, and rate perceived pleasantness.
S2. The out-of-the-magnet tasting session will include three parts:
S2.1 - familiarization with the study procedures. Subjects will be placed in conditions
mimicking the fMRI session: they will be asked to lie in supine position, head placed in a
false head coil, with the gustometer fixed above their mouth and a video screen visible to
them to deliver instructions (visual paradigm created using E-Prime). They also will be
given a rolling wheel to collect feedback. The rest of the session will be spent in this
position. Subjects will then taste the whole range of study drinks (each drink twice, in a
randomized order) and rate their pleasantness on visual analog scales (VAS).
S2.2. - learning picture-drink associations. Three drinks will be chosen based on the
ratings given during the first part of the session (three equally appreciated, well-liked
(VAS score >50) drinks). Subjects will then taste these three drinks repeatedly while
observing abstract pictures. The objective of this sequence is to learn 3 picture-drink
pairs.
S2.3 - associative learning verification. Subjects will taste each of the three drinks and
choose the picture to which each drink has been associated. If they fail once, the S2.2 and
S2.3 sequences will be repeated. If they fail to learn associations at the second
verification, they will be excluded form the study.
S3. The fMRI session's objective is to study cognitive correlates of choice. Subjects will
be placed in a 3Tesla fMRI scanner, with the gustometer, visual screen and rolling wheel
available as in the S2. The functional fMRI scan will be done using high-resolution protocol
(1,5*1,5*1,8mm) covering prefrontal, subcortical and occipital brain areas. Subjects will
undergo 80 tastings. In 50% of tastings, they will view the three previously learned
pictures and freely choose one of them, then receive 1ml of the drink associated with that
picture. In the other 50% of tastings, the picture-drink pair will be received without the
possibility to choose. The "no choice" tastings will be computed according to the results of
"choice" tastings so that each drink will be consumed the same amount of times in "choice"
and "no choice" context.
;
Intervention Model: Single Group Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |